Analyzing the Financial Health of scPharmaceuticals Inc. (SCPH)

Publicly-traded company scPharmaceuticals Inc. (NASDAQ:SCPH) had a closing price of $4.45 yesterday. Meanwhile, the average 12-month price target from Wall Street analysts is currently $9.75, this means that the stock is underpriced by 54.36%. In the past 52 weeks the company’s stock price has moved within the range of $2.44 to $7.85.

This particular stock’s 5-day moving average is 4.46, its 20-day moving average is 4.80 and its 100-day moving average is 5.65. scPharmaceuticals Inc. (SCPH) currently has 18.50M shares outstanding, which means that its market capitalization is $82.32M.

The Details: scPharmaceuticals Inc. (SCPH) Financial Health

Return on Assets, which is expressed as a percentage, tells us how well a public company is using its assets to turn a profit. The larger the percentage, the better it is At the moment, scPharmaceuticals Inc. Return on Assets is -31.00%.

What Does Wall Street Say about Company?

When selecting potential stocks to buy, many investors want to find out what Wall Street professionals are thinking about the company beforehand – like what the average analyst rating is. At the moment, the average analyst rating for SCPH is Overweight. Out of 4 total analysts who were surveyed, 0 rated it a sell, 0 rated it a underweight, 0 rated it an overweight, 1 rated it hold, and 3 rated it a Buy.

Understanding Profitability at scPharmaceuticals Inc. (SCPH)

A good way of assessing a public company’s profitability is by looking at its Earnings per Share (EPS). In the most recent financial results released by scPharmaceuticals Inc., for the quarter ending on 12/2019, the company posted EPS of -0.48. The average estimate of Wall Street analysts had projected -0.36.

Wall Street analysts, on average, are forecasting the company’s EPS to be -0.53, compared to -0.27 reported in the same quarter last year.